A bridge too far for artificial intelligence?: Automatic classification of stanzas in Spanish poetry.

The rise in artificial intelligence and natural language processing techniques has increased considerably in the last few decades. Historically, the focus has been primarily on texts expressed in prose form, leaving mostly aside figurative or poetic expressions of language due to their rich semantics and syntactic complexity. The creation and analysis of poetry have been commonly carried out by hand, with a few computer-assisted approaches. In the Spanish context, the promise of machine learning is starting to pan out in specific tasks such as metrical annotation and syllabification. However, there is a task that remains unexplored and underdeveloped: stanza classification. This classification of the inner structures of verses in which a poem is built upon is an especially relevant task for poetry studies since it complements the structural information of a poem. In this work, we analyzed different computational approaches to stanza classification in the Spanish poetic tradition. These approaches show that this task continues to be hard for computers systems, both based on classical machine learning approaches as well as statistical language models and cannot compete with traditional computational paradigms based on the knowledge of experts.

Month of birth and height. A case study in rural Spain.

INTRODUCTION: Season of birth correlates to a wide range of health conditions throughout life measured by anthropometrics. This study explores whether the month of birth and weather during gestation influence male adult height, based on Spain's rural population before the end of the modernization process. METHODS: The database of heights (N = 16.266) is composed of conscripts who reached the age of 21 between 1908 and 1985 (birth cohorts 1886-1965). The population sample has been taken from a municipality in inner Spain: Hellín, in the region of Castilla-La Mancha, mainly an agrarian area, with poor resources and low income until the 1970 s/1980 s. Two different methodologies have been implemented: a harmonic regression using sinusoidal covariables and a random forest model. RESULTS: we find that being born at the end of the summer and during the autumn was favorable to height. The birth month with the highest statures is September, with heights 0.5 cm above the annual average and 0.9 cm above February, the birth month with the lowest average height. Furthermore, we can observe that rainfall and temperature during gestation had little additional influence due to a substitution effect with the birth month variable. CONCLUSIONS: Our results suggest that the seasonal effects on height can be significant and that it can be partially affected by environmental factors during early life. Our findings could be of interest for low-income populations and developing rural societies.

TEI-friendly annotation scheme for medieval named entities: a case on a Spanish medieval corpus.

Medieval documents are a rich source of historical data. Performing named-entity recognition (NER) on this genre of texts can provide us with valuable historical evidence. However, traditional NER categories and schemes are usually designed with modern documents in mind (i.e. journalistic text) and the general-domain NER annotation schemes fail to capture the nature of medieval entities. In this paper we explore the challenges of performing named-entity annotation on a corpus of Spanish medieval documents: we discuss the mismatches that arise when applying traditional NER categories to a corpus of Spanish medieval documents and we propose a novel humanist-friendly TEI-compliant annotation scheme and guidelines intended to capture the particular nature of medieval entities.

UMA-BCI Speller: An easily configurable P300 speller tool for end users.

BACKGROUND AND OBJECTIVE: Some neurodegenerative conditions can severely limit patients' capability to communicate because of the loss of muscular control. Brain-computer interfaces may help in the restoration of communication with these patients, bypassing the muscular activity, so that brain signals can be directly interpreted by a computer. There are many studies regarding brain-controlled spellers; however, these systems do not usually leap out of the lab because of technical and economic requirements. As a consequence, the potential end users do not benefit from these scientific advances in their daily life. The objective of this paper is to present a novel brain-controlled speller designed to be used by patients due to its versatility and ease of use. METHODS: The brain-computer interface research group of the University of Málaga (UMA-BCI) has developed a speller application based on the well-known P300 potential which can be easily installed, configured and used. The application supports the common P300 paradigms: the Row-Column Paradigm and the Rapid Serial Visual Presentation Paradigm. The inner core of the application is implemented with a widely used and studied platform, BCI2000, which ensures its reliability and allows other researchers to apply modifications at will in order to test new features. Ten naïve volunteers carried out exercises using the application and completed usability tests for evaluation purposes. RESULTS: New subjects using the application managed to set up and use the proposed speller in less than an hour. The positive results of the evaluation through the usability tests support this application's ease of use. CONCLUSIONS: A new brain-controlled spelling tool has been presented whose aim is to be used by severely paralyzed patients in their daily lives, as well as by researchers to test new spelling features.

Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics.

Hyperprolactinemia is an underappreciated/unknown adverse effects of antipsychotics. The consequences of hyperprolactinemia compromise therapeutic adherence and can be serious. We present the consensus recommendations made by a group of experts regarding the management of antipsychotic-induced hyperprolactinemia. The current consensus was developed in 3 phases: 1, review of the scientific literature; 2, subsequent round table discussion to attempt to reach a consensus among the experts; and 3, review by all of the authors of the final conclusions until reaching a complete consensus. We include recommendations on the appropriate time to act after hyperprolactinemia detection and discuss the evidence on available options: decreasing the dose of the antipsychotic drug, switching antipsychotics, adding aripiprazole, adding dopaminergic agonists, and other type of treatment. The consensus also included recommendations for some specific populations such as patients with a first psychotic episode and the pediatric-youth population, bipolar disorder, personality disorders and the elderly population.

Consenso español sobre los riesgos y detección de la hiperprolactinemia iatrogénica por antipsicóticos / Spanish consensus on the risks and detection of antipsychotic drug-related hyperprolactinaemia

Introducción. La hiperprolactinemia iatrogénica (HPRLi) se ha descrito con más frecuencia con algunos antipsicóticos, dependiendo de su capacidad de bloqueo de los receptores de dopamina D2. Existe gran heterogeneidad de la práctica clínica y posiblemente falta de concienciación sobre este problema entre los médicos. Dada la elevada frecuencia con la que los pacientes con enfermedad mental grave reciben antipsicóticos de forma prolongada, se precisa vigilar posibles riesgos en su salud física. La HPRLi y sus síntomas pueden pasar desapercibidos si no se investigan rutinariamente. Metodología. Se realiza una revisión profunda de la literatura para elaborar un consenso multidisciplinario con psiquiatras junto a otros especialistas (de Endocrinología, Medicina Interna y Oncología) con el fin de consensuar los riesgos clínicos y los métodos de detección más adecuados de la HPRLi de acuerdo con los distintos niveles de evidencia científica (I-IV). Resultados. Los síntomas a corto plazo incluyen amenorrea, galactorrea y disfunción sexual (descenso del deseo y disfunción eréctil por hipogonadismo secundario). A medio-largo plazo y relacionado con la disminución de estrógenos, se pueden inducir baja masa ósea (osteopenia y osteoporosis), hipogonadismo, menopausia precoz, incremento del riesgo de algunos tipos de cáncer (mama y endometrio), aumento del riesgo cardiovascular, alteraciones en la inmunidad, dislipidemia y disfunción cognitiva, entre otros. La petición de niveles de PRL debería realizarse al inicio del tratamiento en todos los pacientes que reciben antipsicóticos, aunque no se observen síntomas precoces (amenorrea, galactorrea) por el riesgo de subestimar otros síntomas que pueden aparecen a medio plazo. Se aconseja determinar también niveles de FSL, LH, testosterona y vitamina D. Se recomienda explorar rutinariamente la función sexual, ya que puede ser un síntoma mal tolerado que podría conducir al abandono del tratamiento. Se propone un especial cuidado en niños y adolescentes, así como en pacientes con PRL > 50 ng/ml (intensidad moderada), revisando periódicamente si existe hipogonadismo o disfunción sexual. En los pacientes con PRL > 150 ng/ml debe descartarse siempre un prolactinoma radiológicamente y se debe prestar especial atención a posibles antecedentes de cáncer de mama o endometrio. Se aconseja realizar densitometrías en varones >50 años y en mujeres con amenorrea > 6 meses o menopausia precoz para detectar osteoporosis y evitar riesgo de fracturas por fragilidad (AU)

Introduction. Iatrogenic hyperprolactinaemia (IHPRL) has been more frequently related to some antipsychotic drugs that provoke an intense blockade of dopamine D2 receptors. There is a wide variation in clinical practice, and perhaps some more awareness between clinicians is needed. Due to the high frequency of chronic treatment in severe mental patients, careful attention is recommended on the physical risk. IHPRL symptoms could be underestimated without routine examination. Methodology. An intense scientific literature search was performed in order to draw up a multidisciplinary consensus, including different specialists of psychiatry, endocrinology, oncology and internal medicine, and looking for a consensus about clinical risk and detection of IHPRL following evidence-based medicine criteria levels (EBM I- IV). Results. Short-term symptoms include amenorrhea, galactorrhoea, and sexual dysfunction with decrease of libido and erectile difficulties related to hypogonadism. Medium and long-term symptoms related to oestrogens are observed, including a decrease bone mass density, hypogonadism, early menopause, some types of cancer risk increase (breast and endometrial), cardiovascular risk increase, immune system disorders, lipids, and cognitive dysfunction. Prolactin level, gonadal hormones and vitamin D should be checked in all patients receiving antipsychotics at baseline although early symptoms (amenorrhea-galactorrhoea) may not be observed due to the risk of underestimating other delayed symptoms that may appear in the medium term. Routine examination of sexual dysfunction is recommended due to possible poor patient tolerance and low compliance. Special care is required in children and adolescents, as well as patients with PRL levels >50 ng/ml (moderate hyperprolactinaemia). A possible prolactinoma should be investigated in patients with PRL levels >150 ng/ml, with special attention to patients with breast/endometrial cancer history. Densitometry should be prescribed for males >50 years old, amenorrhea > 6 months, or early menopause to avoid fracture risk (AU)

Spanish consensus on the risks and detection of antipsychotic drug-related hyperprolactinaemia. / Consenso español sobre los riesgos y detección de la hiperprolactinemia iatrogénica por antipsicóticos.

INTRODUCTION: Iatrogenic hyperprolactinaemia (IHPRL) has been more frequently related to some antipsychotic drugs that provoke an intense blockade of dopamine D2 receptors. There is a wide variation in clinical practice, and perhaps some more awareness between clinicians is needed. Due to the high frequency of chronic treatment in severe mental patients, careful attention is recommended on the physical risk. IHPRL symptoms could be underestimated without routine examination. METHODOLOGY: An intense scientific literature search was performed in order to draw up a multidisciplinary consensus, including different specialists of psychiatry, endocrinology, oncology and internal medicine, and looking for a consensus about clinical risk and detection of IHPRL following evidence-based medicine criteria levels (EBM I- IV). RESULTS: Short-term symptoms include amenorrhea, galactorrhoea, and sexual dysfunction with decrease of libido and erectile difficulties related to hypogonadism. Medium and long-term symptoms related to oestrogens are observed, including a decrease bone mass density, hypogonadism, early menopause, some types of cancer risk increase (breast and endometrial), cardiovascular risk increase, immune system disorders, lipids, and cognitive dysfunction. Prolactin level, gonadal hormones and vitamin D should be checked in all patients receiving antipsychotics at baseline although early symptoms (amenorrhea-galactorrhoea) may not be observed due to the risk of underestimating other delayed symptoms that may appear in the medium term. Routine examination of sexual dysfunction is recommended due to possible poor patient tolerance and low compliance. Special care is required in children and adolescents, as well as patients with PRL levels >50ng/ml (moderate hyperprolactinaemia). A possible prolactinoma should be investigated in patients with PRL levels >150ng/ml, with special attention to patients with breast/endometrial cancer history. Densitometry should be prescribed for males >50 years old, amenorrhea>6 months, or early menopause to avoid fracture risk.

Brain-computer interface: proposal of a shaping-based training

INTRODUCTION: Persons affected by certain motor disabilities such as amyotrophic lateral sclerosis can evolve with important motor and speech difficulties in communication. A BCI (Brain Computer Interface) is a system that allows interaction between the human brain and a computer, permitting the user to control a communication channel through his or her brain activity. It is based on the analysis and processing of electroencephalographic (EEG) signals to generate control commands. The present study focuses on the subjects' capability to improve the way they learn to control a BCI system. METHODS: Two training procedures were compared: standard and progressive shaping response. Six volunteers participated in a reversal single-subject ABAC design. RESULTS: The study showed that both procedures are equally effective in producing a differential responding in the EEG signals, with no significant differences between them. Nevertheless, there were significant differences when distinguishing two neuronal responses (relax state and hand-movement imagination). Also, in the analysis of individual signals, an adaptive process for the shaping process and a lower error rate in the idle response appeared. CONCLUSION: Both proposed training procedures, standard and progressive shaping, are equally effective to achieve training of differential responses (imagination of hand/relax) in the interaction with a BCI.

A two-class self-paced BCI to control a robot in four directions.

In this work, an electroencephalographic analysis-based, self-paced (asynchronous) brain-computer interface (BCI) is proposed to control a mobile robot using four different navigation commands: turn right, turn left, move forward and move back. In order to reduce the probability of misclassification, the BCI is to be controlled with only two mental tasks (relaxed state versus imagination of right hand movements), using an audio-cued interface. Four healthy subjects participated in the experiment. After two sessions controlling a simulated robot in a virtual environment (which allowed the user to become familiar with the interface), three subjects successfully moved the robot in a real environment. The obtained results show that the proposed interface enables control over the robot, even for subjects with low BCI performance.

Subjective perception of cognitive deficit in psychotic patients.

The objective of this study is to evaluate the subjective perception of cognitive deficit and how it relates to the perception of patients' relatives. Differences between the subjective perception of cognitive deficits in 107 DSM-IV-diagnosed psychotic patients and that of their relatives or caregivers were evaluated using the GEOPTE Scale. Fair agreement was observed between patient and family perception of cognitive functions, although there were important differences on those items that correspond to social functioning. A high degree of correlation was detected between the scores on this scale and clinical global impression scores, as well as the physicians' global impression of cognitive impairment. Psychotic patients maintain insight as to their cognitive deficits, but they fail to conserve an awareness of their perception of social functioning.

An open-label study of amisulpride in the treatment of mania.

BACKGROUND: Amisulpride is a selective D(2)-D(3) antagonist that has been reported to be effective in the treatment of schizophrenia and major depressive disorder. However, no prospective study to date has assessed the effectiveness and tolerability of this compound in mania. METHOD: Twenty DSM-IV-defined acutely ill manic bipolar patients with a Young Mania Rating Scale (YMRS) score of 20 or more entered this open, prospective, 6-week study. Assessments included the YMRS, the Hamilton Rating Scale for Depression (HAM-D), the Clinical Global Impressions Scale for Bipolar Disorder, Modified (CGI-BP-M), and the systematic report of adverse events. Amisulpride was added to other medications, but other antipsychotics were not allowed. RESULTS: Fourteen patients (70%) completed the study. Using last-observation-carried-forward (LOCF) analyses, amisulpride produced significant improvements on the YMRS (p = .0001), the HAM-D (p < .0141), and the overall (p = .0003), mania (p = .0001), and depression (p = .0268) subscales of the CGI-BP-M. The most common side effect was sedation (N = 5, 25%), but there were also some extrapyramidal symptoms, galactorrhea, insomnia, and agitation. The mean amisulpride dose was 680 mg/day (LOCF) and 786 mg/day in completers. CONCLUSIONS: This first prospective study on amisulpride in the treatment of mania suggests that, despite the limitations of the open, observational design and small sample size, amisulpride may be effective and reasonably safe in the treatment of bipolar mania. D(2) and D(3) antagonism may be involved in the mechanisms of the therapeutic response to antipsychotics in mania.

Attitudes and views on psychiatry: a comparison between Spanish and U.S. medical students.

OBJECTIVE: In order to gain a broader view about the process of recruitment, we decided to compare and analyze the differences between the attitudes and views of Spanish and U.S. medical students towards psychiatry. METHODS: The opinions of 151 students who had completed psychiatry at the end of their fourth year were sought on the basis of their responses to a 33-item questionnaire, using a cross sectional design. RESULTS: Although in general, Spanish students showed a positive attitude towards psychiatry, the opinion about certain aspects like the biopsychosocial concept of illness, salary, social pressure and respect from nonpsychiatry staff were different from U.S. students' opinions. CONCLUSION: These opinions may have influenced the 6% of Spanish students who chose psychiatry as a possible specialty, somewhat higher than the 4.5% of U.S. students.